Literature DB >> 22419225

What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'?

Doris E Payer1, Andy C Dean, Isabelle Boileau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22419225      PMCID： PMC3306883          DOI： 10.1038/npp.2011.309

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  7 in total

1.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

2.  Impairment versus deficiency in neuropsychological assessment: Implications for ecological validity.

Authors:  Noah D Silverberg; Scott R Millis
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

Review 3.  Is cognitive functioning impaired in methamphetamine users? A critical review.

Authors:  Carl L Hart; Caroline B Marvin; Rae Silver; Edward E Smith
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

4.  Effect of methamphetamine dependence on everyday functional ability.

Authors:  Brook L Henry; Arpi Minassian; William Perry
Journal:  Addict Behav       Date:  2010-02-01       Impact factor: 3.913

5.  Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.

Authors:  Ari D Kalechstein; Thomas F Newton; Michael Green
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

6.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Authors:  Julie D Rippeth; Robert K Heaton; Catherine L Carey; Thomas D Marcotte; David J Moore; Raul Gonzalez; Tanya Wolfson; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-01       Impact factor: 2.892

7.  Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

Authors:  Edythe D London; Sara L Simon; Steven M Berman; Mark A Mandelkern; Aaron M Lichtman; Jennifer Bramen; Ann K Shinn; Karen Miotto; Jennifer Learn; Yun Dong; John A Matochik; Varughese Kurian; Thomas Newton; Roger Woods; Richard Rawson; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2004-01
  7 in total
  2 in total

Review 1.  [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].

Authors:  N Arnaud; R Thomasius
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

Review 2.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.